Cargando…

Adrenal oligometastasis cured with stereotactic ablative radiotherapy

Stereotactic ablative radiotherapy (SABR) has emerged as an effective, noninvasive alternative to surgery in patients with oligometastatic disease. Historically, select patients with adrenal oligometastases have been treated with adrenalectomies which can offer durable local control and reasonable s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malone, Julia, Pantarotto, Jason R., Tiberi, David, Malone, Shawn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494600/ https://www.ncbi.nlm.nih.gov/pubmed/32983297 http://dx.doi.org/10.1016/j.radcr.2020.08.056

Ejemplares similares

Stereotactic Radiotherapy for Oligometastasis
por: Otake, Sotaro, et al.
Publicado: (2019)

Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis
por: Katoh, Norio, et al.
Publicado: (2018)

EUS-guided radiofrequency ablation for a left adrenal oligometastasis of an esophageal adenocarcinoma
por: Inderson, Akin, et al.
Publicado: (2018)

Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
por: Poon, Ian, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy in Contralateral Kidney Oligometastasis From Renal Cell Carcinoma in a Nephrectomized Patient
por: Marzo, Alessandro Di, et al.
Publicado: (2021)

Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis
por: Chen, Xuguang, et al.
Publicado: (2021)

Long-term Local Control of Primary Non-small Cell Lung Cancer and Adrenal Oligometastasis with Stereotactic Body Radiotherapy: A Case Report
por: Krzywicki, Victoria, et al.
Publicado: (2019)

Successful treatment of induced oligometastasis and repeated oligoprogression of advanced lung adenocarcinoma with immunotherapy and radiotherapy
por: Lee, Ho Young, et al.
Publicado: (2022)

Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy
por: Burgess, Laura, et al.
Publicado: (2020)

Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
por: Mazzola, Rosario, et al.
Publicado: (2020)

114: Quality Assurance of Radiotherapy During the COVID-19 Pandemic: Impact on Peer Review in 14 Regional Cancer Centres Across Ontario
por: Locke, Gordon, et al.
Publicado: (2021)

Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases
por: van Sörnsen de Koste, John R., et al.
Publicado: (2021)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Diagnosis of oligometastasis
por: Terao, Mayako, et al.
Publicado: (2020)

Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
por: Hiraki, Takao, et al.
Publicado: (2012)

microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015)

Long-term survival after multimodal treatment involving radiotherapy for huge hepatocellular carcinoma with oligometastasis: a case report
por: Lee, Byung Min, et al.
Publicado: (2021)

Photodynamic therapy for treatment of recurrent adenocarcinoma of the lung with tracheal oligometastasis
por: Singh, Harpreet, et al.
Publicado: (2022)

Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report
por: Yeo, Seung-Gu
Publicado: (2017)

Surgery and dose-escalated radiotherapy for a de novo intracranial squamous cell carcinoma of the cerebellopontine angle
por: Mula-Hussain, Layth, et al.
Publicado: (2021)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
por: Chen, Hanbo, et al.
Publicado: (2018)

Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk
por: Schneiders, Famke L., et al.
Publicado: (2023)

Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy
por: Stauder, Michael C, et al.
Publicado: (2013)

Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer
por: Holmes, Oliver Edwin, et al.
Publicado: (2017)

Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy
por: Turchan, William Tyler, et al.
Publicado: (2022)

Radiation-Induced Peripheral Neuropathy After Thoracic Stereotactic Ablative Radiotherapy: Case Report
por: Pham, Ha H., et al.
Publicado: (2022)

Small cell lung cancer with thyroid gland oligometastasis: A case report
por: Tsutsui, Toshiharu, et al.
Publicado: (2020)

Upper tract urothelial carcinoma with Oligometastasis to the right ventricle, surgical considerations, and management
por: Helman, Talia A., et al.
Publicado: (2022)

Oligometastasis: More Lessons to Be Learned
por: Kim, Kyung Hwan, et al.
Publicado: (2023)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

Ablative vs. Non-Ablative Radiotherapy in Palliating Locally Advanced Pancreatic Cancer: A Single Institution Experience and a Systematic Review of the Literature
por: Kamel, Randa, et al.
Publicado: (2023)

Adrenal vein sampling for ACTH-producing pheochromocytomas
por: Leader, Nicholas, et al.
Publicado: (2021)

Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens
por: Siva, Shankar, et al.
Publicado: (2016)

Rapid Detection of Asymptomatic Coronavirus Disease 2019 by Computed Tomography Image Guidance for Stereotactic Ablative Radiotherapy
por: McGinnis, Gwendolyn J., et al.
Publicado: (2020)

Metastasis-directed therapy for oligometastasis and beyond
por: Beckham, Thomas H., et al.
Publicado: (2020)

The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
por: Finkelstein, Steven Eric, et al.
Publicado: (2011)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
por: Lu, Shao-Lun, et al.
Publicado: (2016)

Quality Assurance of Radiotherapy During the Covid-19 Pandemic: Impact on Peer Review in 14 Regional Cancer Centers Across Ontario
por: Locke, G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_85k7qpjq2ksbo7b8avakoj8i53